Aethlon Medical (AEMD) Net Equity Issued and Repurchased (2010 - 2026)

Aethlon Medical (AEMD) has 17 years of Net Equity Issued and Repurchased data on file, last reported at -$848477.0 in Q1 2026.

• Quarterly Net Equity Issued and Repurchased fell 24.68% year-over-year to -$848477.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 46.72% YoY) and the FY2026 annual result came in at $6.9 million, up 46.72% from the prior year.
• Net Equity Issued and Repurchased declined to -$848477.0 in Q1 2026, from $4.0 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.3 million in Q3 2022 to a low of -$848477.0 in Q1 2026.
• A 5-year average of $2.0 million and a median of $1.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased jumped 888.95% — and 2025, when it slumped 1467.52%.
• Tracing AEMD's Net Equity Issued and Repurchased over 5 years: stood at $8.3 million in 2022, then sank by 97.76% to $186501.0 in 2023, then jumped by 888.95% to $1.8 million in 2024, then jumped by 117.17% to $4.0 million in 2025, then tumbled by 121.18% to -$848477.0 in 2026.
• The last three Net Equity Issued and Repurchased figures came in at -$848477.0 (Q1 2026), $4.0 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.